Stay updated on Taldefgrobep Alfa in SMA Clinical Trial

Sign up to get notified when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taldefgrobep Alfa in SMA Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added detailed extension phase dosing for taldefgrobep alfa and placebo, including open-label extension (OLE) phase. Updated the protocol to version 3.4.2 with related update dates (2026-01-30, 2026-02-04, 2026-06).
    Difference
    0.5%
    Check dated 2026-02-11T02:10:06.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Notice about government funding and operation status was added, and the page version updated from v3.4.0 to v3.4.1; these changes do not alter study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T00:40:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Minor UI/metadata updates: added Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T22:40:12.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Locations sections were updated to include a comprehensive list of trial sites across multiple states and Scotland, with Revision: v3.3.3. Previous site groupings were removed/restructured.
    Difference
    2%
    Check dated 2025-12-23T08:20:17.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. This appears to be a non-functional update related to versioning rather than study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-24T17:08:43.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    The page removes a general government funding/operational status notice; core trial details, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T15:00:46.000Z thumbnail image

Stay in the know with updates to Taldefgrobep Alfa in SMA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taldefgrobep Alfa in SMA Clinical Trial page.